首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Indirect atomic absorption determination of atropine, diphenhydramine, tolazoline, and levamisole based on formation of ion-associates with potassium tetraiodometrcurate.
【24h】

Indirect atomic absorption determination of atropine, diphenhydramine, tolazoline, and levamisole based on formation of ion-associates with potassium tetraiodometrcurate.

机译:基于与四碘曲酸钾形成离子缔合的间接原子吸收法测定阿托品,苯海拉明,托拉唑啉和左旋咪唑。

获取原文
获取原文并翻译 | 示例
           

摘要

Ion-associate complexes of atropine sulphate (I), diphenhydramine HCl (II), tolazoline HCl (III) and levamisole HCl (IV) with potassium tetraiodomercurate were precipitated and their solubilities were studied as a function of pH, ionic strength and temperature. Saturated solutions of each ion-associate under the optimum precipitation conditions were prepared and the metal ion-content in the supernatant was determined. The solubility products were thus calculated at different temperatures. A new accurate and precise method using atomic absorption spectrometry for the determination of the investigated drugs in pure solutions and in pharmaceutical preparations is described. The drugs can be determined by the present method in the ranges 13.6--138.8, 5.6-58, 3.6--39.6 and 4.8--48 microg/ml solutions of I--IV, respectively.
机译:沉淀出硫酸阿托品(I),苯海拉明HCl(II),甲苯唑啉HCl(III)和左旋咪唑盐酸盐(IV)与四碘酸钾的离子缔合配合物,并研究了其溶解度随pH,离子强度和温度的变化。制备在最佳沉淀条件下的每种离子缔合的饱和溶液,并测定上清液中的金属离子含量。因此在不同温度下计算溶解度产物。描述了使用原子吸收光谱法测定纯溶液和药物制剂中所研究药物的一种新的精确方法。可以通过本方法在I-IV的13.6--138.8、5.6-58、3.6--39.6和4.8--48 microg / ml溶液中确定药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号